Related references
Note: Only part of the references are listed.Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge
Lindsay A. Courtney et al.
ANNALS OF PHARMACOTHERAPY (2022)
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial
Nuccia Morici et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
Dimitrios Giannis et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
Chia Siang Kow et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2022)
Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity
Jinwen Li et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2022)
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
Maria Marcos-Jubilar et al.
THROMBOSIS AND HAEMOSTASIS (2022)
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
Adam Cuker et al.
BLOOD ADVANCES (2022)
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Behnood Bikdeli et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019
Jintanat Ananworanich et al.
CLINICAL INFECTIOUS DISEASES (2022)
Venous thromboembolism in patients hospitalised with COVID-19 in England
Lara N. Roberts et al.
THROMBOSIS RESEARCH (2022)
New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19-A Large Postmortem and Clinical Analysis
Fabian Heinrich et al.
VIRUSES-BASEL (2022)
The Use of Oral Anticoagulation Is Not Associated With a Reduced Risk of Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies
Meng-Fei Dai et al.
FRONTIERS IN PHARMACOLOGY (2022)
Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis
Baris Gungor et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
Mohamed Abdel-Maboud et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis
Ting Wu et al.
AGE AND AGEING (2021)
Impaired fibrinolysis in critically ill COVID-19 patients
Mirjam Bachler et al.
BRITISH JOURNAL OF ANAESTHESIA (2021)
COVID-19: from3 an acute to chronic disease? Potential long-term health consequences
Victoria Higgins et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2021)
The pathogenesis of microthrombi in COVID cannot be controlled by DOAC: NETosis should be the target
E. Gremese et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients
Rui Zhang et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2021)
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 A Systematic Review and Meta-analysis
David Jimenez et al.
CHEST (2021)
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity
Andrea Spini et al.
PHARMACOLOGICAL RESEARCH (2021)
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
Fien A. von Meijenfeldt et al.
BLOOD ADVANCES (2021)
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker et al.
BLOOD ADVANCES (2021)
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
Michelle Sholzberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial
Alex C. Spyropoulos et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
Parham Sadeghipour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19
Pin Li et al.
JAMA NETWORK OPEN (2021)
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis
Roberta Parisi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization
Matthias M. Engelen et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Venous thromboembolism in COVID-19: A systematic review and meta-analysis
Anastasios Kollias et al.
VASCULAR MEDICINE (2021)
Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: A Meta-Analysis
Changgang Wu et al.
FRONTIERS IN MEDICINE (2021)
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial
Eduardo Ramacciotti et al.
AMERICAN HEART JOURNAL (2021)
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
Dimitrios Giannis et al.
BLOOD (2021)
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial
Usha S. Perepu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
Helen Fogarty et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Renato D. Lopes et al.
LANCET (2021)
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang et al.
LANCET (2021)
Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients
Simone R. Potje et al.
LIFE SCIENCES (2021)
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Patrick R. Lawler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Ewan C. Goligher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
Riccardo Giossi et al.
FRONTIERS IN PHARMACOLOGY (2021)
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker et al.
BLOOD ADVANCES (2021)
Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis
Tarinee Rungjirajittranon et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Ritesh Tandon et al.
JOURNAL OF VIROLOGY (2021)
Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern
EUROSURVEILLANCE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China
Sheng-Qun Deng et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The versatile heparin in COVID-19
Jecko Thachil
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Vittorio Pavoni et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses
Nigel Mackman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Postdischarge venous thromboembolism following hospital admission with COVID-19
Lara N. Roberts et al.
BLOOD (2020)
Postdischarge thrombosis and hemorrhage in patients with COVID-19
Rushad Patell et al.
BLOOD (2020)
Coagulation abnormalities and thrombosis in patients with COVID-19
Marcel Levi et al.
LANCET HAEMATOLOGY (2020)
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Christophe Nougier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis
Syed Shahzad Hasan et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience
Vincenzo Russo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Anticoagulation in Hospitalized Patients with Covid-19
Jehan F. Chowdhury et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Increased Plasma Heparanase Activity in COVID-19 Patients
Baranca Buijsers et al.
FRONTIERS IN IMMUNOLOGY (2020)
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
Luca Costanzo et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2020)
The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin
Paolo Prandoni et al.
THROMBOSIS RESEARCH (2020)
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
Serena Del Turco et al.
THROMBOSIS RESEARCH (2020)
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Anna Cristina Bertoldi Lemos et al.
THROMBOSIS RESEARCH (2020)
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
Vincenzo Russo et al.
FRONTIERS IN MEDICINE (2020)
Venous Thromboembolism in Hospitalized COVID-19 Patients
Gurusaravanan Kutti Sridharan et al.
AMERICAN JOURNAL OF THERAPEUTICS (2020)
Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Yuefei Jin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Long-Term Respiratory and Neurological Sequelae of COVID-19
Fuzhou Wang et al.
MEDICAL SCIENCE MONITOR (2020)
Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545
Naphak Modhiran et al.
ANTIVIRAL RESEARCH (2019)
Vascular Endothelial Cell Biology: An Update
Anne Krueger-Genge et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Heparan Sulfate Proteoglycans as an Attachment Factor for Rabies Virus Entry and Infection
Michihito Sasaki et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Heparin: 100 years of pleiotropic effects
Adilson Ferraz Paschoa
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Endothelial cell control of thrombosis
Jonathan W. Yau et al.
BMC CARDIOVASCULAR DISORDERS (2015)
Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review
Sarah Mousavi et al.
ADVANCES IN PHARMACOLOGICAL SCIENCES (2015)
Venous Thromboembolism in Elderly High-Risk Medical Patients: Time Course of Events and Influence of Risk Factors
Russell D. Hull et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2013)
Mechanics of endothelial cell architecture and vascular permeability
AL Baldwin et al.
CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING (2001)